NYSE$ATR
AptarGroup Inc. · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
AptarGroup's Q1 2022 results showed sales growth and strong top-line performance across all segments, indicating recovery from the global pandemic effects.
AptarGroup reported a 9% increase in sales to $845 million, with core sales up 13%. The company experienced double-digit core sales growth in each segment. Reported earnings per share were $0.93, and adjusted earnings per share were $0.96.
- Reported sales grew 9% and core sales grew 13% with double-digit core growth in each segment.
- Pharma segment posted sales growth in all markets including the prescription drug division as demand for allergic rhinitis and asthma devices began to recover.
- Reported earnings per share of $0.93 compared to $1.24 in the prior year.
- Adjusted earnings per share of $0.96 compared to $1.05 in the prior year.
Headline financials
Revenue & EPS history
AptarGroup · Revenue · Quarterly
$845M
Revenue by segment
AptarGroup · $845M total across 3 segments · Q1 2022
- Beauty$368M+6.1%43.6%
- Pharma$342M+9.1%40.5%
- Closures$134M—15.9%
Forward guidance
Aptar expects earnings per share for the second quarter of 2022, excluding any restructuring expenses, changes in the fair value of equity investments and acquisition costs, to be in the range of $0.92 to $1.02.
Tailwinds
- We are moving forward into the post-pandemic era and we feel very good about the way our businesses are positioned for long-term growth.
- Looking forward to the second quarter, we expect the broad based momentum from the first quarter to continue with growth in each segment
- Including strong growth of our prescription drug device business
- We will continue to manage our operations efficiently
- We mitigate rising costs through pricing initiatives and cost containment.
Headwinds
- Lower demand for at-home COVID-19 tests.
- The war in Ukraine and the COVID-19 outbreak in China are expected to have some impact on our business in the respective regions
- Visibility remains highly uncertain.
- Guidance is based on an effective tax rate range of 27% to 29%
- Currency translation effects
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
+0.3%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.2%
Avg return
30 days after
63%
43 / 68 earnings
Positive
+9.2%
Q4 2017
Best reaction
-9.0%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | -0.8% | -6.4% | |
| Q4 2025 | +8.3% | +12.9% | +6.5% | |
| Q3 2025 | -9.0% | -7.1% | +0.3% | |
| Q1 2025 | +2.3% | +2.1% | +6.8% | |
| Q4 2024 | -8.5% | -9.4% | -2.3% | |
| Q3 2024 | +0.8% | +0.6% | +2.3% | |
| Q2 2024 | +1.7% | +1.1% | +4.4% | |
| Q1 2024 | +2.4% | +3.1% | +5.8% | |
| Q4 2023 | +5.4% | +3.1% | +8.6% | |
| Q3 2023 | +0.1% | -0.9% | +4.2% | |
| Q2 2023 | +3.2% | +2.1% | +6.3% | |
| Q1 2023 | +2.4% | +4.1% | -1.4% | |
| Q4 2022 | +5.7% | +4.2% | +0.3% | |
| Q3 2022 | +2.1% | -1.9% | +6.9% | |
| Q2 2022 | +1.6% | +0.5% | -1.5% | |
| Q1 2022 | +3.4% | +2.5% | -2.0% | |
| Q4 2021 | +3.3% | +3.8% | +2.7% | |
| Q3 2021 | -3.6% | +1.7% | +1.0% | |
| Q2 2021 | -6.3% | -6.6% | -2.3% | |
| Q1 2021 | -0.2% | +2.6% | -2.5% | |
| Q4 2020 | -7.7% | -10.4% | -2.7% | |
| Q3 2020 | +1.6% | +6.4% | +13.3% | |
| Q2 2020 | -3.0% | -0.2% | -0.6% | |
| Q1 2020 | -3.6% | -4.1% | +1.2% | |
| Q4 2019 | -2.6% | -7.0% | -19.6% | |
| Q3 2019 | -7.1% | -8.9% | -6.0% | |
| Q2 2019 | -5.0% | -5.4% | -1.3% | |
| Q1 2019 | +1.3% | +2.3% | +2.0% | |
| Q4 2018 | +1.5% | +0.0% | +2.2% | |
| Q3 2018 | +1.8% | +2.1% | +2.0% | |
| Q2 2018 | +8.6% | +8.1% | +9.6% | |
| Q1 2018 | +0.3% | +0.4% | +1.0% | |
| Q4 2017 | +9.2% | +11.8% | +9.6% | |
| Q3 2017 | -0.6% | -1.6% | -2.5% | |
| Q2 2017 | -6.5% | -6.3% | -6.4% | |
| Q1 2017 | +1.2% | +1.1% | +6.3% | |
| Q4 2016 | +1.7% | +0.4% | +4.4% | |
| Q3 2016 | -4.3% | -7.4% | -0.3% | |
| Q2 2016 | -1.9% | -3.9% | -1.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | +8.3% | — | — | |
| Q1 2015 | +2.4% | — | — | |
| Q4 2014 | +1.8% | — | — | |
| Q3 2014 | +2.0% | — | — | |
| Q2 2014 | -3.5% | — | — | |
| Q1 2014 | -0.1% | — | — | |
| Q4 2013 | +1.9% | — | — | |
| Q3 2013 | +0.2% | — | — | |
| Q2 2013 | -2.1% | — | — | |
| Q1 2013 | -2.0% | — | — | |
| Q4 2012 | -0.8% | — | — | |
| Q3 2012 | -3.5% | — | — | |
| Q2 2012 | +2.6% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q3 2011 | +5.8% | — | — | |
| Q2 2011 | -5.0% | — | — | |
| Q1 2010 | +2.2% | — | — | |
| Q1 2011 | +2.3% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2010 | +2.9% | — | — | |
| Q3 2009 | +2.9% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q2 2009 | +0.5% | — | — | |
| Q2 2010 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro